However, the attenuation of downstream regulators of FASN, as expected from treatment with C75 in the responsive A2780 ovarian cancer cell line, was just partially observed in simvastatin-treated cell lines (Figure 4). This evidence concerns the gene FASN and ovarian carcinoma.